Ray Pritha, De Abhijit, Min Jung-Jun, Tsien Roger Y, Gambhir Sanjiv S
Crump Institute for Molecular Imaging, Department of Molecular and Medical Pharmacology, David Geffen School of Medicine, University of California-Los Angeles, Los Angeles, CA 90095, USA.
Cancer Res. 2004 Feb 15;64(4):1323-30. doi: 10.1158/0008-5472.can-03-1816.
Imaging reporter gene expression in living subjects with various imaging modalities is a rapidly accelerating area of research. Applications of these technologies to cancer research, gene therapy, and transgenic models are rapidly expanding. We report construction and testing of several triple fusion reporter genes compatible with bioluminescence, fluorescence and positron emission tomography (PET) imaging. A triple fusion reporter vector harboring a bioluminescence synthetic Renilla luciferase (hrl) reporter gene, a reporter gene encoding the monomeric red fluorescence protein (mrfp1), and a mutant herpes simplex virus type 1 sr39 thymidine kinase [HSV1-truncated sr39tk (ttk); a PET reporter gene] was found to preserve the most activity for each protein component and was therefore investigated in detail. After validating the activities of all three proteins encoded by the fusion gene in cell culture, we imaged living mice bearing 293T cells transiently expressing the hrl-mrfp-ttk vector by microPET and using a highly sensitive cooled charge-coupled device camera compatible with both bioluminescence and fluorescence imaging. A lentiviral vector carrying the triple fusion reporter gene was constructed and used to isolate stable expressers by fluorescence-activated cell sorting. These stable 293T cells were further used to show good correlation (R(2) approximately 0.74-0.85) of signal from each component by imaging tumor xenografts in living mice with all three modalities. Furthermore, metastases of a human melanoma cell line (A375M) stably expressing the triple fusion were imaged by microPET and optical technologies over a 40-50-day time period in living mice. Imaging of reporter gene expression from single cells to living animals with the help of a single tri-fusion reporter gene will have the potential to accelerate translational cancer research.
利用各种成像方式在活体受试者中对报告基因表达进行成像,是一个快速发展的研究领域。这些技术在癌症研究、基因治疗和转基因模型中的应用正在迅速扩展。我们报告了几种与生物发光、荧光和正电子发射断层扫描(PET)成像兼容的三融合报告基因的构建和测试。发现一个携带生物发光合成海肾荧光素酶(hrl)报告基因、编码单体红色荧光蛋白(mrfp1)的报告基因以及突变的单纯疱疹病毒1型sr39胸苷激酶[HSV1截短的sr39tk(ttk);一个PET报告基因]的三融合报告载体对每个蛋白质组分保留了最大活性,因此对其进行了详细研究。在细胞培养中验证融合基因编码的所有三种蛋白质的活性后,我们通过微型PET并使用与生物发光和荧光成像兼容的高灵敏度冷却电荷耦合器件相机,对携带瞬时表达hrl - mrfp - ttk载体的293T细胞的活体小鼠进行成像。构建了携带三融合报告基因的慢病毒载体,并通过荧光激活细胞分选用于分离稳定表达细胞。这些稳定的293T细胞进一步用于通过用所有三种成像方式对活体小鼠中的肿瘤异种移植物进行成像,显示各组分信号之间具有良好的相关性(R²约为0.74 - )。此外,在40 - 50天的时间段内,通过微型PET和光学技术对稳定表达三融合基因的人黑色素瘤细胞系(A375M)的转移灶在活体小鼠中进行成像。借助单个三融合报告基因从单细胞到活体动物对报告基因表达进行成像,将有可能加速转化癌症研究。 (注:原文中“R²约为0.74 - ”后面似乎缺少完整内容)